MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$24,751K
Research and development
tax credit...
$4,284K
Prepaid expenses and
other current assets
$595K
Other tax receivable
$257K
Total current assets
$29,887K
Equipment, net
$955K
Operating lease right of
use asset
$914K
Other assets
$595K
Total assets
$32,351K
Total liabilities and
stockholders equity
$32,351K
Total stockholders
equity
$23,524K
Total liabilities
$8,827K
Accumulated deficit
-$209,037K
Accumulated other
comprehensive loss
-$737K
Additional paid-in capital
$233,271K
Total current
liabilities
$8,416K
Long-term operating lease
liability
$411K
Common stock, 0.001 par
value, 200,000,000...
$27K
Accounts payable and
accrued liabilities
$7,768K
Operating lease, current
liability
$623K
Accounts payable and
accrued liabilities ...
$25K
Back
Back
Balance Sheet
source: myfinsight.com
Inmune Bio, Inc. (INMB)
Inmune Bio, Inc. (INMB)